Clinical Assessment of Chemosensitivity Test in Xeno-free Culture of Autologous 
Malignant Effusion Cells from Patients with Advanced Lung Adenocarcinoma

A great individual differences to chemotherapeutic effects existed in the patient with advanced lung cancer. How to choose the optimum regimens to achieve the individuation and maximum effect of chemotherapy for lung cancer is worth exploring. The study was designed to examine the effect of ex vitro...

Full description

Saved in:
Bibliographic Details
Published inZhongguo fei ai za zhi Vol. 19; no. 9; pp. 584 - 589
Main Authors Chen, Liang, Yang, Shunfang, Jiang, Jinqi, Zhang, Ying, Feng, Hui, Cao, Jie, Ge, Xinyue, Xie, Wenhui
Format Journal Article
LanguageChinese
Published China Chinese Anti-Cancer Association Chinese Antituberculosis Association 20.09.2016
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A great individual differences to chemotherapeutic effects existed in the patient with advanced lung cancer. How to choose the optimum regimens to achieve the individuation and maximum effect of chemotherapy for lung cancer is worth exploring. The study was designed to examine the effect of ex vitro chemo-sensitivity assay in xeno-free culture of autologous malignant effusion cells from patients with advanced lung adenocarcinoma. The 50 treatment-naive patients with lung adenocarcinoma complicated with malignant pleural or pericardial effusions were enrolled. Effusions of all cases had been controlled by closed drainage and 300 mL-500 mL of which were retained under sterile condition from 25 cases (Chemo-sensitivity group). Primary malignant effusion cells were isolated from autologous effusions of the patients. Then, xeno-free culture (average 11 days) were intervened with 8 chemotherapeutic drugs commonly used in clinical practice and were determined by CCK-8 assay. Optimum regimens were selected for chemot
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1009-3419
1999-6187
DOI:10.3779/j.issn.1009-3419.2016.09.04